Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE5000.1066.65 (+1.35 %)

PREV CLOSE ( ) 4933.45

OPEN PRICE ( ) 4933.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5406

TODAY'S LOW / HIGH ( )4923.40 5023.95

52 WK LOW / HIGH ( )4498.9 6440

NSE5002.2069 (+1.4 %)

PREV CLOSE( ) 4933.20

OPEN PRICE ( ) 4933.20

BID PRICE (QTY) 5002.20 (4)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 208308

TODAY'S LOW / HIGH( ) 4920.30 5026.00

52 WK LOW / HIGH ( )4491.65 6439.9

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

31437.5

33742.8

34146.7

30318.2

Total Expenditure

27524.6

26148.9

26618.4

24231.8

PBIDT (Excl OI)

3912.9

7593.9

7528.3

6086.4

Other Income

1459.6

929.9

1344.8

1203.1

Operating Profit

5372.5

8523.8

8873.09

7289.5

Interest

284.2

360.3

281.4

291.1

Exceptional Items

0.00

PBDT

5088.3

8163.5

8591.7

6998.4

Depreciation

1124.9

852.8

789.1

804.8

Profit Before Tax

3963.4

7310.7

7802.59

6193.6

Tax

733.3

902.8

783

691.2

Provisions and contingencies

Profit After Tax

3230.1

6407.9

7019.59

5502.4

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

3230.1

6407.9

7019.59

5502.4

Minority Interest

-165.3

-149.7

-133.2

-50.8

Shares of Associates

-6.2

Other related items

Misc. Expenses Written off

Consolidated Net Profit

3058.6

6258.2

6886.4

5451.6

Equity Capital

239.1

Face Value (IN RS)

Reserves

Calculated EPS

25.58

52.34

57.60

45.60

Calculated EPS (Annualised)

102.33

209.39

230.41

182.40

No of Public Share Holdings

53651891

53010675

52157635

% of Public Share Holdings

44.87

44.34

43.62

PBIDTM% (Excl OI)

12.44

22.50

22.04

20.07

PBIDTM%

17.08

25.26

25.98

24.04

PBDTM%

16.18

24.19

25.16

23.08

PBTM%

12.60

21.66

22.85

20.42

PATM%

10.27

18.99

20.55

18.14

Notes

Risk Disclosures on Derivatives

Quarterly Results

ALKEM LABORATORIES LTD.